Prostate cancer is a type of cancer that develops in the prostate gland, which is a small gland located in the male reproductive system. The prostate gland produces and secretes the fluid that makes up semen, essential for male fertility. Prostate cancer occurs when the cells in the prostate gland start to grow uncontrollably, forming a tumor.
Prostate cancer is one of the most common types of cancer in men. According to the American Cancer Society, it is estimated that about one in eight men will be diagnosed with prostate cancer during their lifetime. While prostate cancer can occur at any age, it is more commonly diagnosed in older men, with about 60% of cases occurring in men over 65.
Several factors can increase the risk of developing prostate cancer, including age, family history, and race. Men with a close relative, such as a father or brother, who has been diagnosed with prostate cancer are at a higher risk of developing the disease. Additionally, African American men are at a higher risk of developing prostate cancer than men of other races.
Early-stage prostate cancer may not cause any noticeable symptoms. However, symptoms may appear as the cancer grows and spreads to other parts of the body. Some common signs and symptoms of prostate cancer include:
- Frequent urination, especially at night
- Difficulty starting or stopping urination
- Weak urine flow
- Pain or burning during urination
- Blood in the urine or semen
- Pain or discomfort in the pelvic area, lower back, or hips
- Erectile dysfunction
If prostate cancer is suspected, a number of tests may be performed to make a diagnosis. The most common screening test for prostate cancer is a prostate-specific antigen (PSA) blood test. This test measures the level of PSA in the blood, which can be elevated in men with prostate cancer. However, an elevated PSA level can also be caused by other conditions, such as an enlarged prostate or a prostate infection.
If the PSA level is elevated or other symptoms are present, additional tests may be performed, such as a digital rectal exam (DRE) or a prostate biopsy. During a DRE, a healthcare provider will insert a lubricated, gloved finger into the rectum to feel for any abnormalities in the prostate gland. If a suspicious area is found, a biopsy may be performed, which involves taking a small sample of prostate tissue for examination under a microscope.
If prostate cancer is diagnosed, treatment options may include surgery, radiation therapy, chemotherapy, hormone therapy, or a combination of these treatments. The treatment plan will depend on several factors, such as the stage and grade of cancer, the patient’s age and overall health, and personal preferences.
CoreMed Plus can help with prostate cancer screenings through regular check-ups and monitoring. Our healthcare providers can discuss the risks and benefits of prostate cancer screening with patients and help determine the appropriate screening schedule based on individual risk factors. Early detection and treatment can significantly improve outcomes for patients with prostate cancer, and CoreMed Plus is committed to helping our patients stay healthy and informed about their cancer risk.